SCD and chronic myelogenous leukemia, BCR-ABL1 positive: The inhibition of SCD1 accelerates the development of chronic myeloid leukemia (Zhang et al., 2012), which might indicate the potential differential role of SCD1 in solid tumor and hematological tumor.